Overview
This series explains donor human milk banking as a whole-pathway judgment: donor support and milk variability come before processing, while screening, hygiene, cold-chain control, pooling, treatment, testing and traceability jointly shape safety and access. Holder pasteurization reduces many microbial hazards but changes selected heat-sensitive biology, so molecular findings must be kept separate from functional and clinical claims. HTST, HPP and freeze-drying offer promising preservation signals, yet their broader safety, outcome evidence, operational readiness and equity remain conditional. The result is a disciplined way to compare methods without treating safer milk as unchanged or laboratory preservation as proven clinical superiority.
Learning outcomes
- Donor-milk safety is a chain of controls; no single temperature substitutes for screening, hygiene, cold storage, testing and traceability.
- Holder pasteurization at 62.5 °C for 30 minutes reduces many microbial hazards but is not sterilization and alters selected heat-sensitive components.
- Processing effects are component-specific: immune proteins and enzymes are sensitive, while total HMOs and many trace elements appear relatively stable; lipid findings vary.
- HTST, HPP and freeze-drying show preservation signals, but adoption requires safety validation, clinical relevance, feasible operations and equitable access.
Keywords
Preview every chapter · Unlock full text, audio, and video from chapter 4
PlansFAQ
Why is donor human milk banked if mother’s own milk is preferred?
Donor human milk is banked as a bridge for preterm or low-birthweight infants when mother’s own milk is unavailable or insufficient; it does not replace breastfeeding.
Does Holder pasteurization sterilize donor human milk?
No. Holder pasteurization at 62.5 °C for 30 minutes reduces many bacterial and viral hazards, but Bacillus spores can survive and post-treatment testing remains needed.
What does processing change in donor human milk?
Processing changes components unevenly: Holder pasteurization is associated with losses in selected immune proteins and enzymes, while total HMOs and many trace elements appear relatively stable; lipid findings vary.
Are HTST or HPP better than Holder pasteurization?
No universal answer is established: cited studies report better preservation of selected components with HTST or HPP, but clinical superiority and system readiness remain unproven.